Patent details

301143 Product Name: Tralokinumab

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
301143
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1942939
Status:
SPC granted but not yet in force
Application number:
301143
Procedural language:
Dutch
First Applicant Residence Country:
United Kingdom (GB)

Marketing Authorization

Marketing Authorization Number:
EU/1/21/1554
Marketing Authorization Type:
EEA
Marketing Authorization Date:
18/06/2021
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
03/11/2021
First Marketing Authorization date:
18/06/2021
Grant date:
10/02/2022
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
04/11/2021
SPC/SPC Extension Expiration Date:
28/09/2031
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
03/11/2021
 
 

 

Name:
MEDIMMUNE LIMITED
Address:
Milstein Building Granta Park, CAMBRIDGE CAMBRIDGESHIRE CB21 6GH, United Kingdom (GB)

Agent

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
03/11/2021
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC
Journal edition number:
07/22
Publication date:
16/02/2022
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

2

Bulletin Heading:
SPC
Journal edition number:
45/21
Publication date:
10/11/2021
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Annual Fee

Annual Fee(s) Due Date:
30/09/2026
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
10/02/2022 Outgoing Correspondence Decision grant 1 PDF /2/1/7/9/3/0800739712/docs/301143_9_461809l504a.pdf
10/02/2022 Certificate Certificate 1 PDF /2/1/7/9/3/0800739712/docs/301143_10_spcmedcertificate20220210090920396.pdf
28/01/2022 SPC Documents Annex SPC 1 PDF /2/1/7/9/3/0800739712/docs/301143_11_supplprotectioncertificate20220128010746088.pdf
28/01/2022 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /2/1/7/9/3/0800739712/docs/301143_12_incomingcorrespondencepaper20220128010853460.pdf
30/12/2021 Outgoing Correspondence Letter to applicant 1 PDF /2/1/7/9/3/0800739712/docs/301143_8_445967l173.pdf
05/11/2021 Outgoing Correspondence Confirmation receipt request 1 PDF /2/1/7/9/3/0800739712/docs/301143_5_444321l174.pdf
04/11/2021 Application Form First filed application form 2 PDF /2/1/7/9/3/0800739712/docs/301143_1_applicationform20211105085847509.pdf
03/11/2021 SPC Documents Annex SPC 10 PDF /2/1/7/9/3/0800739712/docs/301143_0_supplprotectioncertificate20211103125234960.pdf
03/11/2021 SPC Documents Annex SPC 1 PDF /2/1/7/9/3/0800739712/docs/301143_2_supplprotectioncertificate20211103125310599.pdf
03/11/2021 SPC Documents Annex SPC 2 PDF /2/1/7/9/3/0800739712/docs/301143_3_supplprotectioncertificate20211103125708369.pdf
03/11/2021 SPC Documents Annex SPC 26 PDF /2/1/7/9/3/0800739712/docs/301143_4_supplprotectioncertificate20211103125708392.pdf
03/11/2021 SPC Documents Marketing Authorization SPC 3 PDF /2/1/7/9/3/0800739712/docs/301143_6_supplprotectioncertificate20211103125753272.pdf
03/11/2021 SPC Documents Summary of the characteristics of the product 18 PDF /2/1/7/9/3/0800739712/docs/301143_7_supplprotectioncertificate20211103125708339.pdf